ArticleInvestigational new drugs2022

NSC305787, a pharmacological ezrin inhibitor, exhibits antineoplastic activity in pancreatic cancer cells.

Jean Carlos Lipreri da Silva et al.PubMed ↗Publisher ↗

No numbers read from the abstract.